Inventor profile of:

Claudio Giuliano

City:

Como

Country:

Italy

Published Applications:

25

Last publication date:

2025-12-04

Top Assignees for applications by Claudio Giuliano

The entities that hold a legal rights for patent applications filed by inventor Giuliano Claudio:

Recent patent applications by Giuliano Claudio

Claudio Giuliano from Como, IT has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-12-04
US20250367181A1
Human necessities

Centrally-Active Ghrelin Agonist and Medical Uses Thereof

#2 | 2025-07-24
US20250235442A1
Human necessities

Piperidine Urea Derivatives for Use as Inotropic Agents

#3 | 2025-06-26
US20250205216A2
Human necessities

Piperidine Urea Derivatives for Use as Inotropic Agents

#4 | 2024-09-05
US20240293388A1
Human necessities

New Centrally-Active Ghrelin Agonist and Medical Uses Thereof

#5 | 2024-08-22
US20240277688A1
Human necessities

Piperidine Urea Derivatives for Use as Inotropic Agents

#6 | 2024-01-04
US20240000791A1
Human necessities

Methods of Using 4-Amino-N-[4-(Methoxymethyl)Phenyl]-7-(1-Methylcyclopropyl)-6-(3-Morpholinoprop-1-YN-1-YL)-7H-Pyrrolo[2,3-D]Pyrimidine-5-Carboxamide for the Treatment of Tumors

#7 | 2023-05-25
US20230158007A1
Human necessities

Centrally-active ghrelin agonist and medical uses thereof

#8 | 2022-12-22
US20220401463A1
Human necessities

Process for the synthesis of substituted chloromethyl dialkylphosphates

#9 | 2022-10-27
US20220340541A1
Chemistry; metallurgy

Fumarate salt of (R)-3-(1-(2,3-dichloro-4-(pyrazin-2-yl)phenyl)-2,2,2-trifluoroethyl)-1-methyl-1-(1-methylpiperidin-4-yl)urea, methods of preparation, and uses thereof

#10 | 2020-12-24
US20200399240A1
Chemistry; metallurgy

Fosnetupitant chloride hydrochloride having improved stability

#11 | 2020-09-24
US20200299260A1
Chemistry; metallurgy

Fumarate salt of (R)-3-(1-(2,3-dichloro-4-(pyrazin-2-yl)phenyl)-2,2,2- trifluoroethyl)-1-methyl-1-(1-methylpiperidin-4-yl) urea, methods of preparation, and uses thereof

#12 | 2020-08-20
US20200262850A1
Chemistry; metallurgy

SUBSTITUTED ASYMMETRIC UREAS AS MODULATORS OF GHRELIN RECEPTOR ACTIVITY

#13 | 2019-06-13
US20190177296A1
Chemistry; metallurgy

Substituted piperaziniums for the treatment of emesis

#14 | 2019-02-28
US20190062352A1
Chemistry; metallurgy

Substituted asymmetric ureas as modulators of ghrelin receptor activity

#15 | 2018-07-12
US20180194788A1
Chemistry; metallurgy

Solution comprising the chloride hydrochloride salt of 4-(5-(2-(3,5-bis(trifluoromethyl)phenyl)-N,2-dimethylpropanamido)-4-(o-tolyl)pyridin-2-yl)-1-methyl-1-((phosphonooxy)methyl)piperazin-1-IUM-(fosnetupitant) and palonosetron hydrochloride in combination with dexamethasone as a neurokinin receptor modulator

#16 | 2018-02-15
US20180044293A1
Chemistry; metallurgy

Asymmetric ureas and medical uses thereof

#17 | 2017-09-28
US20170275301A1
Chemistry; metallurgy

Benzenesulfonyl-asymmetric ureas and medical uses thereof

#18 | 2017-05-25
US20170145038A1
Chemistry; metallurgy

Substituted asymmetric ureas as modulators of ghrelin receptor activity

#19 | 2017-02-23
US20170050993A1
Chemistry; metallurgy

Substituted piperaziniums for the treatment of emesis

#20 | 2015-09-10
US20150252021A1
Chemistry; metallurgy

Asymmetric piperidinyl-substituted ureas as medicines

#21 | 2015-01-08
US20150011510A1
Chemistry; metallurgy

4-(5-(2-(3,5-bis(trifluoromethyl)phenyl)-N,2-dimethylpropanamido)-4-(o-tolyl)pyridin-2-yl)-1-methyl-1-((phosphonooxy)methyl)piperazin-1-ium as a neurokinin receptor modulator

#22 | 2014-05-01
US20140121210A1
Chemistry; metallurgy

Asymmetric ureas and medical uses thereof

#23 | 2013-09-05
US20130231315A1
Chemistry; metallurgy

Methods of treating emesis

#24 | 2013-04-23
US13478361
-

Substituted 4-phenyl pyridines having anti-emetic effect

#25 | 2012-08-30
US20120220629A1
Chemistry; metallurgy

Asymmetric ureas and medical uses thereof

InventorID:

425465 ⎘